Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with ...

How common is endometrial cancer? In the United States, cancer of the endometrium (the lining of the uterus) is the most common cancer of the female reproductive organs. The American Cancer Society ...

Baylor College of Medicine in Houston is at the forefront of advancements in breast cancer treatment by pioneering a "right-sizing surgery", potentially eliminating the need for surgery, chemotherapy, ...

Giving patients with a common form of breast cancer an immunotherapy drug before surgery appears to boost outcomes, a n ...

Initially launching in Germany, the app will soon be available in the UK, Australia, Canada, and other markets.

Individual patient data from neoadjuvant randomized breast cancer clinical trials with available data on pathologic complete ...

Sarah's account came just months ahead of World Cancer Day (February 4), an international initiative to raise awareness of cancer and its impacts. Around 56,800 new breast cancer cases arise in the UK ...

A far shorter, simpler, and less toxic treatment protocol for patients with triple-negative breast cancer produced outcomes ...

As it was, there was a good chance I could fight it - but I would have to have a complete mastectomy on my left breast and a lumpectomy on the right. I went into shock. My husband and I both ...

A Complete Unknown could see Timothée Chalamet become the youngest-ever Best Actor winner after he picked up his second Oscars nomination for his portrayal of Bob Dylan. James Mangold's new movie ...

Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, ...